The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - GlaxoSmithKline; Jenapharm; Medac; MSD Oncology; Roche Pharma AG
Speakers' Bureau - Jenapharm; Medac; Roche Pharma AG
Research Funding - Medac; MSD (Inst); Roche Pharma AG (Inst); Vaccibody (Inst)
Travel, Accommodations, Expenses - Medac
Clinical characterization of long term survivors (LTS) in ovarian cancer (OC): Results of a propensity score matched (PSM) analysis of the international prospective tumor bank for ovarian cancer (TOC Network).
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Fujirebio Diagnostics; Roche
Consulting or Advisory Role - Fujirebio Diagnostics; Glycotope GmbH
Research Funding - Myriad Genetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Fujirebio Diagnostics; GlaxoSmithKline; Tesaro
 
Hannah Woopen
Travel, Accommodations, Expenses - Medac
 
Joanna Glajzer
No Relationships to Disclose
 
Oliver Hunsicker
No Relationships to Disclose
 
Linn Woelber
No Relationships to Disclose
 
Aarne Feldheiser
No Relationships to Disclose
 
Els van Nieuwenhuysen
No Relationships to Disclose
 
Michael D Mueller
No Relationships to Disclose
 
Nicole Concin
Travel, Accommodations, Expenses - Roche Pharma AG
 
Patrick Achimas
No Relationships to Disclose
 
Ilary Ruscito
No Relationships to Disclose
 
Sven Mahner
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Tesaro; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Pierluigi Benedetti Panici
No Relationships to Disclose
 
Maria Luisa Gasparri
No Relationships to Disclose
 
Andrea Papadia
Consulting or Advisory Role - Roche Pharma AG
 
Michael J. Birrer
Consulting or Advisory Role - Acceleron Pharma; Merrimack; Oxigene; Roche/Genentech; Sanofi; Threshold Pharmaceuticals
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); Array Biopharma (Inst); AstraZeneca (Inst); Biogen (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Endocyte (Inst); Fresenius (Inst); GE Healthcare (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Hampton Medical Conferences (Inst); Intuitive Surgical (Inst); Janssen-Cilag (Inst); Kendle (Inst); Lilly (Inst); MedImmune (Inst); Menarini (Inst); Merck Sharp & Dohme (Inst); Morphotek (Inst); Nektar (Inst); Novo Nordisk (Inst); Oasmia Pharmaceutical AB (Inst); PharmaMar (Inst); Phillips Gilmore Oncology (Inst); Quintiles (Inst); Roche (Inst); Sanofi (Inst); Schering-Plough (Inst); Sigma-Tau (Inst); Telik (Inst); TRM Oncology (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Eisai (Inst); Exelixis (Inst); Fresenius Biotech (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst); Merrimack (Inst); Morphotek (Inst); Nektar (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Proacta (Inst); Quintiles (Inst); Roche (Inst); Sandoz (Inst); Sanofi (Inst); Schering-Plough (Inst); Vifor Pharma (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GCI Health; Oasmia Pharmaceutical AB; PharmaMar; Roche
 
Silvia Darb-Esfahani
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Jalid Sehouli
Honoraria - AstraZeneca; PharmaMar; Roche Pharma AG; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Novogene; Roche Pharma AG; Tesaro
Research Funding - Amgen (Inst); Bayer (Inst); Lilly (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - PharmaMar; Roche Pharma AG